Healthcare provider profile · identity verified

Mohammad Ashraf Toor, MD

Internal Medicine · NEW LENOX, IL · NPI 1841289691

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	494	147
Atorvastatin Calcium	Atorvastatin Calcium	288	93
Hydrochlorothiazide	Hydrochlorothiazide	279	79
Gabapentin	Gabapentin	236	79
Metoprolol Succinate	Metoprolol Succinate	220	62
Metformin Hcl	Metformin Hcl	207	63
Albuterol Sulfate Hfa	Albuterol Sulfate	194	55
Lisinopril	Lisinopril	190	65
Furosemide	Furosemide	171	50
Pantoprazole Sodium	Pantoprazole Sodium	161	51
Hydralazine Hcl	Hydralazine Hcl	158	49
Levothyroxine Sodium	Levothyroxine Sodium	149	41
Losartan Potassium	Losartan Potassium	149	44
Potassium Chloride	Potassium Chloride	141	37
Carvedilol	Carvedilol	133	39
Naproxen	Naproxen	115	32
Eliquis	Apixaban	111	32
Ibuprofen	Ibuprofen	93	30
Simvastatin	Simvastatin	91	30
Clopidogrel	Clopidogrel Bisulfate	88	22
Metoprolol Tartrate	Metoprolol Tartrate	88	29
Omeprazole	Omeprazole	87	29
Alprazolam	Alprazolam	80	19
Montelukast Sodium	Montelukast Sodium	80	18
Diclofenac Sodium	Diclofenac Sodium	71	25
Rosuvastatin Calcium	Rosuvastatin Calcium	68	16
Azithromycin	Azithromycin	66	44
Clonidine Hcl	Clonidine Hcl	61	23
Glipizide	Glipizide	59	15
Alcohol Prep Pads	Alcohol Antiseptic Pads	58	16
Glimepiride	Glimepiride	58	15
Allopurinol	Allopurinol	54	16
Donepezil Hcl	Donepezil Hcl	54	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	14
Jardiance	Empagliflozin	47	14
Baclofen	Baclofen	46	14
Doxazosin Mesylate	Doxazosin Mesylate	46	suppressed
Enalapril Maleate	Enalapril Maleate	46	14
Lidocaine	Lidocaine	46	15
Promethazine Hcl	Promethazine Hcl	46	11
Tamsulosin Hcl	Tamsulosin Hcl	45	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	suppressed
Spironolactone	Spironolactone	40	16
Ventolin Hfa	Albuterol Sulfate	40	11
Trazodone Hcl	Trazodone Hcl	39	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	14
Tramadol Hcl	Tramadol Hcl	38	14
Levetiracetam	Levetiracetam	37	13
Xarelto	Rivaroxaban	37	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	35	suppressed
Ezetimibe	Ezetimibe	35	15
Amoxicillin	Amoxicillin	34	19
Famotidine	Famotidine	34	11
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	22
Lovastatin	Lovastatin	31	suppressed
Meclizine Hcl	Meclizine Hcl	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Nebivolol Hcl	Nebivolol Hcl	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Dexlansoprazole Dr	Dexlansoprazole	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Folic Acid	Folic Acid	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	26	suppressed
Sertraline Hcl	Sertraline Hcl	26	suppressed
Lorazepam	Lorazepam	25	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	23	suppressed
Risperidone	Risperidone	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Diltiazem Hcl	Diltiazem Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Lactulose	Lactulose	22	suppressed
Nitroglycerin	Nitroglycerin	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	22	11
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	19	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	19	11
Azelastine-Fluticasone	Azelastine/Fluticasone	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Megestrol Acetate	Megestrol Acetate	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	13
Bumetanide	Bumetanide	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Ozempic	Semaglutide	17	suppressed
Valsartan	Valsartan	17	suppressed
Vascepa	Icosapent Ethyl	17	suppressed
Atenolol	Atenolol	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Fenofibrate	Fenofibrate	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Nystatin	Nystatin	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Icosapent Ethyl	Icosapent Ethyl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Methimazole	Methimazole	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Prednisone	Prednisone	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Cephalexin	Cephalexin	11	11
Colestipol Hcl	Colestipol Hcl	11	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	11	suppressed
Finasteride	Finasteride	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error